Med. praxi. 2013;10(1):16-21

Options of immunomodulatory therapy in the management of recurrent respiratory infections

doc.MUDr.Jaromír Bystroň, CSc.
Oddělení alergologie a klinické imunologie Fakultní nemocnice Olomouc

The author presents a review article on the options of immunomodulatory therapy of recurrent respiratory infections (RRI). He first focuses

on defining the term RRI and, next, on possible immunomodulatory strategies in the management of these conditions, with a particular

regard to the options for general practitioners. He deals in detail with bacterial immunomodulators and the drug OLIMUNOVAC that he

has most clinical experience with and that can be used in field practice by general practitioners.

Keywords: recurrent infections, immune disorder, treatment

Published: January 15, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Bystroň J. Options of immunomodulatory therapy in the management of recurrent respiratory infections. Med. praxi. 2013;10(1):16-21.
Download citation

References

  1. Eggenberger K. Les infections des voies respiratoires les plus fréquentes chez l´enfant dans la practique ambulatoire. Ars Medici 1993; 8: 24-30.
  2. Geslin P. Beta-lactam antibiotics and multiple resistant pneumococci isolatér in France (1984-1994). Méd et Hyg 1995; 53: 2111-2118.
  3. Bal L, et al. Chemotherapy for chronic bronchitis controversies. Presse Med 1995; 24: 189-194. Go to PubMed...
  4. Bystroň J. Bakteriální imunomodulátory - současné použití v klinické praxi. Remedia 2010; 20(5): 298-304.
  5. Bystroň J, Petrů V, Krčmová I, a spol. Účinnost a bezpečnost perorálního bakteriálního imunomodulátoru OLIMUNOVAC u pacientů s častými infekcemi dýchacích cest. Alergie 2011; 13(1): 58-65.
  6. Jeseňák M, Rennerová Z, Bánovčin P, a kol. Recidivujíce infekcie dýchacích ciest a imunomodulácia u dětí. Mladá fronta, edice Eskulap 2012.
  7. Heřt J. Alternativní medicína a léčitelství. Kritický pohled. www.sysifos.cz/files/Alternativni_medicina_Hert.pdf.




Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.